Syneos Health Toekomstige groei
Future criteriumcontroles 3/6
Syneos Health zal naar verwachting groeien in winst en omzet met respectievelijk 33.7% en 1.4% per jaar. De winst per aandeel zal naar verwachting groeien met 40.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 9.7% zijn.
Belangrijke informatie
33.7%
Groei van de winst
40.1%
Groei van de winst per aandeel
Life Sciences winstgroei | 18.4% |
Inkomstengroei | 1.4% |
Toekomstig rendement op eigen vermogen | 9.7% |
Dekking van analisten | Good |
Laatst bijgewerkt | 28 Sep 2023 |
Recente toekomstige groei-updates
Recent updates
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 29Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?
Mar 10Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?
Feb 20Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?
Dec 20Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?
Nov 28Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors
Nov 01Syneos, Datavant expand partnership on data analytics for clinical trials
Oct 11Syneos Health falls 13% after update on outlook
Sep 13When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?
Sep 08Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Aug 22Syneos Health Q2 2022 Earnings Preview
Aug 01With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case
Jul 19Syneos: Upside Could Be Priced In, Valuations Unsupportive
Jul 15Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?
Jun 18Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Jun 03We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt
May 19Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?
Apr 08Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors
Mar 27Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?
Mar 05Is Syneos Health (NASDAQ:SYNH) A Risky Investment?
Feb 18Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?
Feb 03With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting
Jan 04Syneos Health's Double-Digit Revenue Growth Sets The Tone For A Strong 2022
Dec 03Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?
Dec 03Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2025 | 5,478 | 267 | 467 | 463 | 7 |
12/31/2024 | 5,250 | 220 | 463 | 451 | 7 |
12/31/2023 | 5,146 | 43 | 336 | 438 | 8 |
6/30/2023 | 5,419 | 71 | 162 | 253 | N/A |
3/31/2023 | 5,414 | 148 | 289 | 387 | N/A |
12/31/2022 | 5,393 | 266 | 334 | 427 | N/A |
9/30/2022 | 5,407 | 287 | 392 | 489 | N/A |
6/30/2022 | 5,419 | 278 | 323 | 405 | N/A |
3/31/2022 | 5,340 | 242 | 325 | 394 | N/A |
12/31/2021 | 5,213 | 235 | 393 | 450 | N/A |
9/30/2021 | 4,980 | 251 | 337 | 379 | N/A |
6/30/2021 | 4,730 | 236 | 444 | 486 | N/A |
3/31/2021 | 4,461 | 198 | 542 | 591 | N/A |
12/31/2020 | 4,416 | 193 | 375 | 425 | N/A |
9/30/2020 | 4,489 | 192 | 420 | 472 | N/A |
6/30/2020 | 4,567 | 187 | 324 | 390 | N/A |
3/31/2020 | 4,720 | 195 | 229 | 293 | N/A |
12/31/2019 | 4,676 | 131 | 255 | 318 | N/A |
9/30/2019 | 4,608 | 86 | 208 | 270 | N/A |
6/30/2019 | 4,546 | 17 | 272 | 322 | N/A |
3/31/2019 | 4,452 | 19 | 292 | 337 | N/A |
12/31/2018 | 4,390 | 24 | 249 | 303 | N/A |
9/30/2018 | 3,995 | -36 | 221 | 280 | N/A |
6/30/2018 | 3,472 | -174 | 104 | 165 | N/A |
3/31/2018 | 2,658 | -184 | 21 | 76 | N/A |
12/31/2017 | 1,853 | -138 | 154 | 198 | N/A |
9/30/2017 | 1,365 | -86 | 81 | 124 | N/A |
6/30/2017 | 1,033 | 89 | 128 | 163 | N/A |
3/31/2017 | 1,033 | 116 | N/A | 186 | N/A |
12/31/2016 | 1,030 | 113 | N/A | 109 | N/A |
9/30/2016 | 1,009 | 106 | N/A | 159 | N/A |
6/30/2016 | 984 | 116 | N/A | 154 | N/A |
3/31/2016 | 952 | 109 | N/A | 160 | N/A |
12/31/2015 | 915 | 117 | N/A | 205 | N/A |
9/30/2015 | 887 | 33 | N/A | 155 | N/A |
6/30/2015 | 860 | 8 | N/A | 146 | N/A |
3/31/2015 | 837 | 0 | N/A | 144 | N/A |
12/31/2014 | 810 | -27 | N/A | 131 | N/A |
9/30/2014 | 770 | 13 | N/A | 142 | N/A |
6/30/2014 | 732 | -1 | N/A | 121 | N/A |
3/31/2014 | 687 | -27 | N/A | 86 | N/A |
12/31/2013 | 652 | -42 | N/A | 37 | N/A |
12/31/2012 | 579 | -60 | N/A | 43 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei SYNH ( 33.7% per jaar) ligt boven de spaarquote ( 2.2% ).
Winst versus markt: De winst van SYNH ( 33.7% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.4% per jaar).
Hoge groeiwinsten: De winst van SYNH zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van SYNH ( 1.4% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 9% per jaar).
Hoge groei-inkomsten: De omzet van SYNH ( 1.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen SYNH zal naar verwachting over 3 jaar laag zijn ( 9.7 %).